Existing drugs for Hepatitis C multiply the effect of the COVID-19 antiviral remdesivir
Credit
Jenna Leucke/U. of Texas at Austin
Usage Restrictions
None
License
Licensed content
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.